Can virulence factors be viable antibacterial targets?

Author: Marra, Andrea

Source: Expert Review of Anti-Infective Therapy, Volume 2, Number 1, February 2004 , pp. 61-72(12)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

There is a real crisis in healthcare with the emergence of bacterial pathogens resistant to multiple drugs. The drug discovery industry is faced with the challenge of developing new classes of antibiotics that are effective against resistant organisms. Targeting bacterial virulence is one approach that has yet to be fully exploited, and the last decade or so has seen the development of reagents, screens and approaches that could make this possible. Several processes utilized by bacteria to cause infection are employed in a wide range of pathogens and as such may make attractive targets. Inhibitors of such targets would be unlikely to affect host cells, be cross-resistant to existing therapies and induce resistance themselves.

Keywords: in-vivo; screens; in-vivo; targets; pathogenesis; surrogate models; virulence targets

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14787210.2.1.61

Publication date: 2004-02-01

More about this publication?

Expert Review of Anti-infective Therapy provides expert reviews on therapeutics and diagnostics in the treatment of infectious disease. Coverage includes antibiotics, drug resistance, drug therapy, infectious disease medicine, antibacterial, antimicrobial, antifungal and antiviral approaches, and diagnostic tests.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites